Shapira E, Ben-Yoseph Y, Nadler H L
Clin Chim Acta. 1977 Aug 1;78(3):359-63. doi: 10.1016/0009-8981(77)90068-7.
The complex of trypsin with purified alpha2-macroglobulin from normals and patients with cystic fibrosis was studied. The formed complex failed to reveal any proteolytic activity toward a high molecular weight substrate whereas the esterolytic activity towards a low molecular weight substrate was retained. This esterolytic activity was resistant to inhibition by a high molecular weight inhibitor. During iincubation at 38 degrees C the complex with normal alpha2-macroglobulin was slowly inhibited by the high molecular weight inhibitor and regained activity with the high molecular weight substrate. This phenomenon was not obtained when the alpha2-macroglobulin from cystic fibrosis was examined. These data suggest that the gradual conversion of normal alpha2-macroglobulin-trypsin complex into an alpha2-macroglobulin fragment-trypsin complex is deficient in patients with cystic fibrosis.
对来自正常人和囊性纤维化患者的纯化α2-巨球蛋白与胰蛋白酶的复合物进行了研究。形成的复合物对高分子量底物未显示出任何蛋白水解活性,而对低分子量底物的酯解活性得以保留。这种酯解活性对高分子量抑制剂的抑制具有抗性。在38℃孵育期间,与正常α2-巨球蛋白形成的复合物被高分子量抑制剂缓慢抑制,并对高分子量底物恢复活性。当检测来自囊性纤维化患者的α2-巨球蛋白时,未观察到这种现象。这些数据表明,囊性纤维化患者中正常α2-巨球蛋白-胰蛋白酶复合物向α2-巨球蛋白片段-胰蛋白酶复合物的逐渐转化存在缺陷。